IRTC
iRhythm Technologies, Inc. NASDAQ$120.80
Mkt Cap $3.9B
52w Low $105.62
14.3% of range
52w High $212.00
50d MA $124.26
200d MA $157.46
P/E (TTM)
-86.9x
EV/EBITDA
-1557.1x
P/B
25.3x
Debt/Equity
4.8x
ROE
-29.2%
P/FCF
164.5x
RSI (14)
—
ATR (14)
—
Beta
1.18
50d MA
$124.26
200d MA
$157.46
Avg Volume
583.5K
About
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagno…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | -0.56 | -0.43 | +23.2% | 129.16 | -1.8% | -6.5% | — | — | — | — | — | — |
| Feb 19, 2026 | AMC | 0.02 | 0.17 | +750.0% | 158.88 | -2.2% | -5.0% | -11.1% | -13.7% | -14.5% | -11.8% | -25.6% | — |
| Oct 30, 2025 | AMC | -0.36 | -0.06 | +83.3% | 184.12 | +12.7% | +1.7% | +0.5% | -1.6% | -2.0% | -3.6% | -0.7% | — |
| Jul 31, 2025 | AMC | -0.53 | -0.32 | +39.6% | 140.18 | +11.6% | +17.7% | +17.7% | +14.4% | +11.3% | +14.8% | +22.0% | — |
| May 1, 2025 | AMC | -0.89 | -0.95 | -6.7% | 108.59 | +10.3% | +20.7% | +25.0% | +24.5% | +25.4% | +26.2% | +29.5% | — |
| Feb 20, 2025 | AMC | -0.29 | 0.01 | +103.4% | 112.67 | +5.3% | +6.0% | +5.5% | +1.1% | -2.9% | -5.4% | -6.0% | — |
| Oct 30, 2024 | AMC | -0.55 | -1.26 | -129.1% | 75.77 | -10.3% | -4.4% | -1.0% | +7.5% | +14.4% | +18.1% | +14.8% | — |
| Aug 1, 2024 | AMC | -0.92 | -0.61 | +33.7% | 84.22 | -10.7% | -12.3% | -16.0% | -13.5% | -18.7% | -15.9% | -19.3% | — |
| May 2, 2024 | AMC | -0.99 | -1.47 | -48.5% | 110.88 | -1.8% | -7.4% | -3.7% | -4.2% | -10.9% | -9.9% | -24.2% | — |
| Feb 22, 2024 | AMC | -0.60 | -1.26 | -110.0% | 115.07 | -4.4% | -8.7% | -7.8% | +2.9% | +2.8% | +3.1% | -2.1% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Needham | Maintains | Buy → Buy | — | $129.16 | $126.82 | -1.8% | -6.5% | — | — | — | — |
| May 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $129.16 | $126.82 | -1.8% | -6.5% | — | — | — | — |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $129.16 | $126.82 | -1.8% | -6.5% | — | — | — | — |
| May 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $129.16 | $126.82 | -1.8% | -6.5% | — | — | — | — |
| May 1 | JP Morgan | Maintains | Overweight → Overweight | — | $129.16 | $126.82 | -1.8% | -6.5% | — | — | — | — |
| Apr 15 | Truist | Maintains | Buy → Buy | — | $123.23 | $122.27 | -0.8% | +1.0% | -0.5% | +1.7% | +1.4% | -3.5% |
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $120.49 | $118.98 | -1.3% | -1.9% | -4.4% | -0.0% | +2.3% | +3.3% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $116.80 | $116.80 | +0.0% | +0.4% | +1.6% | +3.2% | +1.2% | -1.3% |
| Mar 11 | Citigroup | Maintains | Buy → Buy | — | $120.53 | $120.73 | +0.2% | -0.7% | -4.9% | -6.2% | -5.6% | -2.5% |
| Feb 23 | Truist | Maintains | Buy → Buy | — | $150.96 | $148.13 | -1.9% | -6.5% | -9.2% | -10.0% | -7.1% | -11.4% |
Recent Filings
8-K
iRhythm Technologies, Inc. -- 8-K Filing
iRhythm Technologies reported Q1 2026 results, demonstrating operational performance in its digital health care platform focused on disease detection and prevention capabilities.
Apr 30
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
IRTC's auditor resignation suggests potential accounting disagreements or internal control concerns, which raises red flags about financial reliability and could pressure the stock until a reputable replacement is secured.
Apr 1
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Uncertainty around leadership transitions at UnitedHealth could create near-term stock volatility, though investors should monitor whether the successor demonstrates capability to navigate ongoing regulatory pressures in healthcare.
Mar 12
8-K
iRhythm Holdings, Inc. -- 8-K Filing
iRhythm Holdings reported fourth quarter and full year 2025 financial results, providing investors with updated performance metrics for the digital health company's device detection and disease prevention operations.
Feb 19
Data updated apr 25, 2026 4:17pm
· Source: massive.com